BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34035120)

  • 1. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
    Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
    Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
    Tanaka A
    Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
    Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
    Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of primary sclerosing cholangitis with increased IgG4 levels.
    Manganis CD; Chapman RW; Culver EL
    World J Gastroenterol; 2020 Jun; 26(23):3126-3144. PubMed ID: 32684731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis.
    Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Ohara H; Joh T
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1104-9. PubMed ID: 25594435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
    Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
    J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
    Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
    Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating Primary Sclerosing Cholangitis from Similar Diseases of Autoimmune Origin.
    Kunovsky L; Dite P; Hornakova L; Dolina J; Uvirova M; Kojecky V; Martinek A; Jabandziev P
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):398-403. PubMed ID: 34551027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.